$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Microdialysis is a commonly used technique in neuroscience research. During the last 50 years, the minimal-invasive microdialysis technique has been continuously improved to become a well-established method to monitor local concentrations of small molecular weight compounds in the extracellular space. Nearly every interstitial tissue fluid can be investigated in freely moving animals.
Gaddum introduced the push-pull technique in the 1960s. He modified an approach from Feldberg et al. in which tubocurarine was perfused through a cannula ending in the lateral ventricle and collecting the effluent also via a cannula1. Gaddum developed the push-pull technique in which a cannula consisting of two concentric steel needles was implanted in distinct brain areas and perfused by a solution while simultaneously removing the neurotransmitters released from the neurons surrounding the tip2. Unfortunately, tissue damage caused by the cannula around the tip limited the application of this method. As a further advancement of this method, Bito and coworkers introduced a dialysis bag method in which the collected solution was separated from the surrounding tissue by a dialysis membrane. They implanted a dialysis sac into the subcutaneous tissue of dog necks. The content of the dialysis bag is protein-free and could be analyzed many weeks later for ions and amino acids3. The next development was the dialytrode, a primitive microdialysis probe, which originally was described by Delgado in 19724. Finally, Ungerstedt and colleagues improved the design of microdialysis probe so that it was smaller and displaced less tissue5.
A concentric microdialysis probe behaves similarly to a blood capillary. The system is constantly perfused by a solution featuring the ionic composition of the surrounding tissue fluid while lacking the analyte of interest. The dialysis membrane exposed to the external solution or tissue is semi-permeable. It permits passive diffusion of substances into the probe along their concentration gradient6. The permeability is dependent on many variables such as molecular weight, shape, charge and pH of the compound. It is also limited due to properties of the membrane material, pore size of the membrane and flow rate7.
Figures 1 and 2 show a concentric microdialysis probe. The perfusion fluid enters via an inlet tubing into the metal sleeve, which surrounds the fused silica. Inside the metal sleeve, it streams down along the fused silica and leaves it on its tip. In the space between the dialysis membrane and the Polytetrafluoroethylene (PTFE)-tubing (such as Teflon) the perfusion fluid then flows upward. Here, diffusion of substances from the tissue occurs which surround the membrane. The dialysate leaves the probe through the PTFE-tubing, which is connected to outlet tubing and can be collected.
The microdialysis technique has several advantages relative to other in vivo techniques. The probe constitutes a physical barrier with the result that the dialysate contains no enzymes or cells. Therefore, there is no need for purification of the eluate prior to analysis, and no enzymatic degradation of analytes takes place. Oxidative degradation can occur during passage of analytes in the tubing, but this can often be prevented by adding an antioxidant (e.g. ascorbic acid) to the perfusate. Alternatively, oxidative damage to neuropeptides, for instance, was efficiently suppressed by replacing the outlet tubing with a tip to collect the dialysate8. The dialysate can be investigated directly with nearly any kind of analytical method and multiple analytes can be collected simultaneously. This system can be used in awake animals, and nearly all brain regions can be examined. Moreover, infusion of drugs through the probe is possible (retrodialysis). However, there are also limitations of the microdialysis technique. The somewhat low time resolution does not provide real-time information regarding neurotransmitter changes. Because it is an invasive technique, probe implantation causes surgical trauma and anesthesia, which can affect neurotransmitter concentrations, is required during this step7,9,10.
The compound concentration in the dialysate comprises only a small amount of the actual compound concentration in the extracellular fluid. For calculation of the unknown compound concentration in the extracellular fluid, relative in vitro recovery has to be calculated. Determination of individual relative in vitro recoveries for every probe and every compound is necessary before starting the in vivo experiment. For this purpose, the probe is dipped into a solution containing the analyte of interest whereas the perfusion fluid is the same solution lacking the analyte of interest. After determination of compound concentrations in the dialysate, this data has to be referred to their concentration in the surrounding fluid. In vitro recovery determinations of several substances can be implemented simultaneously9.
Many neuroscience research groups use the microdialysis technique to investigate neurotransmitters and metabolites in the extracellular space of distinct brain areas. Thus, commercial probes are in great demand in the neuroscience research environment. A great advantage of commercially available probes is the high functional reliability. The experimental set-up for commercial probes is well established and validated for many well-known neurotransmitters and metabolites. However, whereas the commercially available microdialysis equipment is expensive and has less flexibility in application11, in this work a microdialysis probe assembly is presented in detail, which can be adapted to any application and can be manufactured for less than $10. This custom-made probe is a concentric microdialysis probe tested for investigations in various brain areas8.
In vitro probe recoveries of substances with different molecular weight (range of 100-1,600 Da) and with different physicochemical properties are compared. In vitro recovery determination of glucose, lactate and acetylcholine with a molecular weight less than 200 Da, ATP with a molecular weight of approximately 500 Da and the neuropeptides angiotensin II, substance P and somatostatin with a molecular weight above 1,000 Da is performed.